Anyone who has ever listened to "Kiss an Angel Good Morning" knows who Charley Pride is. He was as American as "Burgers and Fries and Cherry Pies" and the darling of Nashville at a time when his picture was kept off albums because he was black. Regardless of his race, he became country music's first black superstar, the first African American performer to appear onstage at the Grand Ole Opry, and the first to be inducted into the Country Music Hall of Fame.
But Charley also shares a distinction that caused his death. Being African American placed him at higher risk from COVID-19, and this virus caused his death. Progressive physicians like Dr. Peter McCullough from Baylor, Dr. Harvey Risch from Yale, Dr. George Fareed from Harvard, and most recently Dr. Pierre Kory from the University of Wisconsin, have demonstrated the near 100 percent effectiveness of early outpatient treatment using repurposed drugs — and they have shared this with the Nation via Senate Hearings in November and December.
Dr. Pierre Kory, in emotional testimony this week, declared, "You know who's dying here? It's our African American and Latino and elderly. It's some of the most disadvantaged and impoverished members of our society. They are dying at higher rates than anyone else. It's the most severe discrepancy I've seen in my medical career. And we are responsible for protecting those disadvantaged members. We have a special duty to provide countermeasures. The amount of evidence to show Ivermectin is lifesaving and protective is so immense, and the drug is so safe. It must be implemented — I'm asking the NIH to review our data and come up with recommendations."
Many doctors who have employed early outpatient treatment have found it to be 100 percent effective at preventing COVID-19 death — this author included. Dr. Brian Tyson used early outpatient treatment and saved 1,900 infected patients. The earlier the treatment is given, the better.
Dr. Pierre Kory stated that any deaths now, knowing that early outpatient treatment is lifesaving, are preventable. The Kory Count is the running tally of the number of COVID-19 deaths that could have been prevented using such early outpatient treatment. Dr. Peter McCullough asked the FDA to approve early outpatient treatment on November 19, 2020. No answer and no approval.
My patients receive it. None have died from COVID. Not a single one of Dr. Brian Tyson's patients who received it died. If Charley Pride had received it, would we be reading about his death today? I think not.
How many more have to die before the FDA and CDC recognize and provide Emergency Use Authorization and guidance so that ALL physicians can use early outpatient treatment to save their patients? Will our country uphold its duty to protect the most impoverished and vulnerable in our society — our African Americans and Latinos?
Let us all join together and ask — no — let us insist that the FDA review Dr. Kory's data not tomorrow — but today — and issue guidance on early outpatient treatment. The FDA's official policy remains zero early outpatient treatment, which is unacceptable to me, my patients, and their families. It should be unacceptable to you as well.
Today's Kory Count stands at 45,591
The “Kory Count” of preventable deaths with early outpatient treatment:
November 19: Dr. Peter McCullough requests FDA approval in Senate Hearing
November 20: 1,952
November 21: 1,429
November 22: 843
November 23: 1,039
November 24: 2,209
November 25: 2,313
November 26: 1,179
November 27. 1,412
November 28: 1,192
November 29: 818
November 30: 1,265
December 1: 2,610
December 2: 2,885
December 3: 2,857
December 4: 2,637
December 5: 2,190
December 6: 1,111
December 7: 1,533
December 8: 2,821
December 8: Dr. Pierre Kory repeats request for approval of early outpatient treatment
December 9: 3,157
December 10: 2,937
December 11: 2,951
December 12: 2,251 including Charley Pride
By Justus R. Hope, M.D.
Author, Surviving Cancer, COVID-19, and Disease: The Repurposed Drug Revolution